Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues

Donghui Zhou, Gang Pan, Zheng Chen, Jingjing Zheng, Li-Ping Yian, Xiaodong TengBMC 2008 · DOI

Abstract

RON expression is significant in gastric carcinoma tissue and corresponding paraneoplastic tissue, but is not expressed in normal gastric mucosa. Expression of RONΔ165 was similarly observed in gastric carcinoma tissue and in metastases present in lymph node tissues. We hypothesize that RON and its splice variant play an important role in the occurrence, progression, and metastasis of gastric carcinoma, and therefore may represent a useful marker to evaluate the biological activity of gastric carcinoma.

Introduction

Gastric carcinoma remains a leading cause of cancer-related mortality worldwide, particularly in East Asia. Identifying molecular drivers of invasion and metastasis is crucial for developing better diagnostics and targeted treatments. The RON (Recepteur d’origine nantais) receptor, a member of the MET proto-oncogene family, has been implicated in various cancers, but its specific role in gastric cancer was previously poorly understood. This study investigates whether RON expression serves as a reliable marker for tumor aggressiveness and patient prognosis.

Methods and Materials

The researchers conducted a retrospective study using tissue samples from 98 patients who underwent surgery for gastric carcinoma between 1998 and 2003. Two primary techniques were employed:

  1. Immunohistochemistry (IHC): Used to visualize RON protein localization in 98 cancer samples, 29 paraneoplastic samples (adjacent to the tumor), and 10 healthy controls.
  2. Western Blotting: A sensitive technique used on a subset of fresh samples (19 cancer, 8 normal mucosa, 2 normal lymph nodes) to detect total protein levels and specifically identify the RONΔ165 splice variant, known for its increased oncogenic potential.

Molecular findings were correlated with clinical data, including TNM stage, histological grade, and patient survival over a follow-up period of up to 89 months.

Results

Immunohistochemical Analysis of RON Expression

A key finding was the "all-or-nothing" expression pattern: RON was completely absent in normal gastric mucosa but present in 56.1% of gastric carcinoma tissues ($p = 0.007$). Furthermore, RON was detected in 25.6% of paraneoplastic tissues, suggesting its expression may be an early event in malignant transformation.

Immunohistochemical staining of RON in gastric tissues showing varied expression levels across different samples.

RON expression significantly correlated with invasive depth ($p = 0.019$), lymph node metastasis ($p = 0.019$), and TNM stage ($p = 0.001$).

Identification of the RONΔ165 Splice Variant

Western blot analysis confirmed the presence of the RONΔ165 variant exclusively in cancerous tissues and metastatic lymph nodes. This variant appears to be a specific marker for malignancy and metastatic potential.

Western blot analysis showing RON (165kDa) and β-actin expression in tumor (T), paraneoplastic (P), lymph node metastasis (L), normal mucosa (N), and normal lymph node (NL) samples.

Discussion and Conclusion

While RON expression is a strong indicator of tumor progression and metastasis, it did not significantly predict overall survival in this specific cohort ($p = 0.195$). This suggests that while RON drives aggressive behavior, other factors also influence final clinical outcomes.

The high specificity of RON and its Δ165 variant for malignant tissue makes them promising candidates for future targeted therapies, such as siRNA-based gene silencing or monoclonal antibodies, aimed at halting metastatic progression in gastric carcinoma.

Summary updated

Abstract

RON expression is significant in gastric carcinoma tissue and corresponding paraneoplastic tissue, but is not expressed in normal gastric mucosa. Expression of RONDelta165 was similarly observed in gastric carcinoma tissue and in metastases present in lymph node tissues. We hypothesize that RON and its splice variant play an important role in the occurrence, progression, and metastasis of gastric carcinoma, and therefore may represent a useful marker to evaluate the biological activity of gastric carcinoma.
BibTeX
@inproceedings{zhou2008expression,
  author = {Donghui Zhou and Gang Pan and Zheng Chen and Jingjing Zheng and Li-Ping Yian and Xiaodong Teng},
  title = {{Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues}},
  booktitle = {BMC},
  year = {2008},
  doi = {10.1186/1471-2407-8-353},
}
Figure